Cetera Investment Advisers’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,843
| Closed | -$64.8K | – | 3739 |
|
|
2024
Q2 | $64.8K | Sell |
4,843
-51,760
| -91% | -$692K | ﹤0.01% | 3570 |
|
|
2024
Q1 | $2.63M | Buy |
56,603
+54,570
| +2,684% | +$2.53M | 0.01% | 1364 |
|
|
2023
Q4 | $137K | Buy |
2,033
+889
| +78% | +$60.1K | ﹤0.01% | 2107 |
|
|
2023
Q3 | $82.8K | Buy |
1,144
+204
| +22% | +$14.8K | ﹤0.01% | 2111 |
|
|
2023
Q2 | $70K | Sell |
940
-359
| -28% | -$26.7K | ﹤0.01% | 2109 |
|
|
2023
Q1 | $69.1K | Buy |
1,299
+408
| +46% | +$21.7K | ﹤0.01% | 2081 |
|
|
2022
Q4 | $60.2K | Sell |
891
-407
| -31% | -$27.5K | ﹤0.01% | 2030 |
|
|
2022
Q3 | $162K | Buy |
1,298
+952
| +275% | +$119K | ﹤0.01% | 1526 |
|
|
2022
Q2 | $33K | Buy |
+346
| New | +$33K | ﹤0.01% | 1785 |
|